Instadose Pharma Corp
OTC:INSD
Balance Sheet
Balance Sheet Decomposition
Instadose Pharma Corp
Instadose Pharma Corp
Balance Sheet
Instadose Pharma Corp
| Nov-2016 | Nov-2017 | Nov-2018 | Nov-2019 | Nov-2020 | Nov-2021 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-88%
|
0
-91%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+555%
|
0
+156%
|
0
+69%
|
0
+45%
|
0
+97%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
-178%
|
0
-70%
|
0
-45%
|
0
-97%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-88%
|
0
-91%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
75
|
75
|
75
|
75
|
75
|
75
|
|